Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Aero Capital Solutions Acquires Twenty A320 Family Aircraft From easyJet Through Sale-and-Leaseback
Aero Capital Solutions, Inc.February 11, 2021 GMT
AUSTIN, Texas, Feb. 11, 2021 (GLOBE NEWSWIRE) Aero Capital Solutions, Inc. (ACS), a leading mid-life aircraft leasing platform, is pleased to announce the acquisition of twenty A320 family aircraft from easyJet Airline Company Limited on a sale-and-leaseback basis. The transactions were completed in two tranches during 2020.
“Working collaboratively with our airline partners, we are able to build highly competitive and tailored solutions which support fleet development needs,” said Daniel Watson, ACS’ Chief Commercial Officer. “easyJet is one of the leading low-cost carriers in Europe, and including this recent transaction, is strategically well-positioned to emerge from the pandemic even stronger than before.”
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stem, Inc. Brings Smart Energy Storage to Electric Cooperative Projects with Today’s Power, Inc.
Stem, Inc.February 11, 2021 GMT
MILLBRAE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) Stem, Inc. (“Stem”), a global leader in artificial intelligence (AI)-driven clean energy storage systems, today announced the Company will provide smart energy storage services to Today’s Power, Inc. (“TPI”), a renewable energy company based in North Little Rock, Ark. that develops, owns and operates renewable energy assets. A certified partner in Stem’s Partner Program, TPI will leverage Stem’s smart energy storage solution to deliver energy flexibility in electric cooperative projects, starting in Northwest Arkansas.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Pacific Biosciences of California, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial .
Pacific Biosciences of California, Inc.February 10, 2021 GMT
MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2020. Reported revenue is consistent with the Company’s press release issued on January 11, 2021.
Q4 2020 Financial Highlights
Revenue for the fourth quarter of 2020 was $27.1 million, representing a 42% increase sequentially compared with $19.1 million for the third quarter of 2020 and a 3% decrease compared with $27.9 million for the fourth quarter of 2019. The Company placed 35 Sequel II/IIe systems during the fourth quarter, bringing the total installed base of Sequel II/IIe systems up to 203 as of December 31, 2020, compared with 1
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal .
Myovant Sciences, Inc.February 11, 2021 GMT
ORGOVYX™ (relugolix) approved by the
U.S. Food and Drug Administration (FDA) in December 2020 as the first and only oral GnRH receptor antagonist for adult patients with advanced prostate cancer; ORGOVYX launched in the U.S. in early January 2021
Announced collaboration with Pfizer in December 2020 to jointly develop and commercialize relugolix in oncology and relugolix combination tablet in women’s health in the U.S. and Canada